Shape Therapeutics

ShapeTX is pioneering the field of programmable RNA medicines with the vision of repairing the genetic causes of disease. Led by a dynamic team of scientists and industry veterans, the company combines artificial intelligence (AI) and RNA technology to make life-saving medicines accessible. The utilization of AI enables ShapeTX to analyze massive datasets generated across its technology suite and therapeutic portfolio, driving intelligent decision making in the creation of effective, safe, and affordable medicines.

At the core of ShapeTX's approach is the recognition of RNA's therapeutic potential, which allows for the redesign of cellular machinery to address the underlying causes of numerous diseases. The ShapeTX platform employs advanced AI techniques and RNA-related technologies to discover and formulate new medications that are not only effective but also easy to manufacture on a large scale. The company has made significant progress in areas such as RNA editing and gene therapy, demonstrating an unwavering commitment to addressing hard-to-treat conditions while ensuring that innovations reach patients in need.